Global Antibiotic R&D Partnership (GARDP) hompage.
At the beginning of 2018, GARDP launched an education and outreach project named REVIVE (revive.gardp.org) with an objective to capture old and new knowledge and skills in antimicrobial drug discovery and R&D as well as to support and connect the antimicrobial R&D community. As part of our educational activities we organize regular (free of charge) webinars about topics relevant to antimicrobial R&D. The presentations in these webinars are always complemented by an extensive question and answer session, which is very appreciated by our participants.
In Europe, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) supports us by disseminating information about our webinars. As antimicrobial resistance is a global problem and research is actively taking place in many areas, we are very keen to engage researchers worldwide.
Title:
Natural products antibiotics: from traditional screening to novel discovery approaches.
Speaker:
Olga Genilloud, Scientific Director, Fundación MEDINA, Granada, Spain.
Moderator:
Laura Piddock, Director of Scientific Affairs, GARDP
Date and time:
3 October, 17:00-18:30 CEST. Find your time zone here.
Register here for this live webinar.
Title:
Converting Gram-positive-only compounds into broad-spectrum antibiotics.
Speaker:
Paul Hergenrother, Kenneth L. Rinehart Endowed Chair in Natural Products Chemistry, University of Illinois.
Moderator:
Laura Piddock, Director of Scientific Affairs, GARDP.
Date and time:
7 November, 17:00-18:30 CET. Find your time zone here.
Register here for this live webinar.
REVIVE BLOG
Journey towards a better antimicrobial pipeline; is there light at the end of the tunnel?
In GARDP’s REVIVE Blog, we invite experts of different aspects of antimicrobial resistance (AMR) to share their knowledge and opinions about the current status and the future challenges of this field. In the latest blog post, Colm Leonard (National Institute for Health and Care Excellence, NICE) and Tracy Parker (Department of Health and Social Care, DHSC) discuss the UK’s new project to develop innovative evaluation and purchasing models for antimicrobials.
Read the full article here and join the discussion.